Connection
Jacob Houghton to Deferoxamine
This is a "connection" page, showing publications Jacob Houghton has written about Deferoxamine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.235 |
|
|
|
-
Houghton JL, Zeglis BM, Abdel-Atti D, Aggeler R, Sawada R, Agnew BJ, Scholz WW, Lewis JS. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer. Proc Natl Acad Sci U S A. 2015 Dec 29; 112(52):15850-5.
Score: 0.118
-
Houghton JL, Zeglis BM, Abdel-Atti D, Sawada R, Scholz WW, Lewis JS. Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses. J Nucl Med. 2016 Mar; 57(3):453-9.
Score: 0.117